BANK 2017-BNK8 appoints new special servicer for mortgage loan
BANK 2017-BNK8 has appointed Torchlight Loan Services as the new special servicer for its Colorado Center mortgage loan, impacting the asset-backed securities industry.
Silexion Therapeutics boosts authorized share capital by 500M
Silexion Therapeutics Corp increases authorized share capital by 500 million shares, enhancing its financial flexibility and growth potential.
Mirum Pharmaceuticals Reports Positive Results for ATEBRIOZ
Mirum Pharmaceuticals shares positive results from the PROGRESS study for ATEBRIOZ in pediatric patients with fibrodysplasia ossificans progressiva.
Cumberland Pharmaceuticals to Submit New Drug Application for Ifetroban
Cumberland Pharmaceuticals plans to submit a New Drug Application for ifetroban, targeting cardiomyopathy in Duchenne muscular dystrophy patients.
CV Sciences settles arbitration with former legal counsel
CV Sciences, Inc. settles arbitration with former legal counsel for $500,000, enhancing its financial position and focusing on core operations.
GrafTech updates costs for Mexico facility closure
GrafTech International Ltd. revises cost estimates for closing its Monterrey facility, signaling a strategic operational shift.
HPS Corporate Lending Fund Declares New Share Distributions
HPS Corporate Lending Fund announces regular and variable supplemental distributions for its common shares, impacting shareholder returns and industry strategies.
Seres Therapeutics CFO Marella Thorell Resigns, Transition Ahead
Marella Thorell resigns as CFO of Seres Therapeutics, effective November 15, 2026, as the company prepares for a leadership transition.
Earth Science Tech CFO Resignation Sparks Leadership Change
Earth Science Tech, Inc. announces CFO Ernesto L. Flores' resignation, with CEO Giorgio R. Saumat stepping in as interim CFO. Leadership transition impacts company strategy.
Gladstone Commercial Corp Announces Board Resignation, New Director
Gladstone Commercial Corp's Board of Directors sees a leadership change as Walter H. Wilkinson Jr. resigns, with George Stelljes appointed as Lead Independent Director.
Gladstone Land Corp appoints new Lead Independent Director
Gladstone Land Corp announces Walter H. Wilkinson Jr.'s resignation and George Stelljes' appointment as Lead Independent Director, marking a leadership transition.
Gladstone Capital Corp announces board leadership change
Gladstone Capital Corp announces the resignation of Walter H. Wilkinson Jr. from its Board and the appointment of George Stelljes as Lead Independent Director.
Maplebear to Wind Down Caper Cart Operations, Incurs Charges
Maplebear Inc. plans to wind down Caper Cart operations, expecting $55M to $80M in charges. This strategic decision impacts the business services sector.
LQR House Inc. Chief Marketing Officer Resigns
LQR House Inc. announces the resignation of Chief Marketing Officer Jaclyn Hoffman, impacting its marketing strategies in the competitive beverage industry.
Civista Bancshares appoints Jeremy Normington-Slay to Board
Civista Bancshares has appointed Jeremy Normington-Slay to its Board of Directors, enhancing its leadership in the state commercial banking sector.
Mobility Global grants new stock awards to executives
Mobility Global Inc. announces restricted stock unit awards for executives, highlighting a strategic focus on leadership incentives in the business services sector.
Gyre Therapeutics announces new employment agreements for CEO, CFO
Gyre Therapeutics, Inc. secures leadership with new agreements for CEO Ying Luo and CFO Thomas Eastling, emphasizing stability in the pharmaceutical sector.
AquaBounty Technologies Reports Key Updates in 8-K Filing
AquaBounty Technologies files an 8-K with significant updates impacting operations and the fishing industry, signaling potential shifts in market dynamics.
Golub Capital Private Credit Fund Announces October Distributions
Golub Capital Private Credit Fund reveals its October 2026 distributions for Class I and Class S shares, emphasizing commitment to shareholder returns.
Aardvark Therapeutics shares new data from HERO trial
Aardvark Therapeutics announces exploratory efficacy data from its HERO trial, potentially impacting the pharmaceutical preparations industry.